Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1.
doi: 10.1097/HEP.0000000000001428. Online ahead of print.

Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in hepatocellular carcinoma

Chien-Hao Huang  1   2 , Wei-Ting Ku  1   3 , Jayashri Mahalingam  1   4 , Cheng-Heng Wu  1 , Tsung-Han Wu  2   5 , Jian-He Fan  1 , Chung-Wei Su  1   2 , Po-Ting Lin  1   2 , Chien-Wei Peng  1   2 , Chan-Keng Yang  2   6 , Wei Teng  1   2 , Wen-Juei Jeng  1   2 , Wei-Ting Chen  1   2 , Chen-Chun Lin  1   2 , Shi-Ming Lin  1   2 , I-Shyan Sheen  1   2 , Yung-Chang Lin  2   6 , Chun-Yen Lin  1   2
Affiliations

Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in hepatocellular carcinoma

Chien-Hao Huang et al. Hepatology. .

Abstract

Background and aims: CD4+ regulatory T cells (Tregs) are pivotal in HCC progression. However, systemic depletion of all Tregs risks autoimmunity. Existing subgroup classifications highlight Tregs' phenotypic and functional heterogeneity but lack coherent consensus. This study aimed to classify Treg subtypes using single-cell CITE-seq, integrating data from tumor, non-tumor, and blood samples in HCC patients. We also validated the clinical relevance and prognostic value of this classification.

Methods: CITE-seq analysis was performed on 51,067 CD4+ T cells from eight HCC patients. Validation involved 96 HCC patients and 53 healthy donors using flow cytometry, functional assays, and clinical data.

Results: Trajectory and TCR analyses identified a peripheral Foxp3high Treg subset that preferentially migrate to tumor sites, acquiring a terminally differentiated, activated phenotype. These tumor-infiltrating Foxp3high Tregs exhibit elevated LAYN and TRM signatures and further increase their Foxp3 expression and immunosuppressive functions by pro-inflammatory cytokines in tumor tissue. The CCL5/CCR5 axis is crucial for recruiting Foxp3high Tregs from peripheral blood into the tumor microenvironment. A strong correlation was observed between the percentage of Foxp3high Tregs in peripheral blood and their counterparts in tumor regions, suggesting their potential as peripheral biomarker. Notably, a peripheral Foxp3high Tregs/CD4+ T cells percentage>3.5% predicted overall survival and early recurrence, with AUROCs exceeding 0.75.

Conclusion: Peripheral Foxp3high Tregs migrate to tumor sites via the CCR5-CCL5 axis and mature in response to pro-inflammatory cytokines. The proportion of these Tregs in peripheral blood correlates with their presence in tumors, making them a potential biomarker for predicting HCC outcomes.

Keywords: Peripheral Foxp3high Treg cells; Single-cell Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITEseq); hepatocellular carcinoma; immunotherapy; overall survival and early recurrence.

PubMed Disclaimer

LinkOut - more resources